Showing results (271-280 of 474) with videos related to
Sort By:
Pageof 48
Journal of Hepatology|May 10, 2019
Glycolytic activation of peritumoral monocytes fosters immune privilege via the PFKFB3-PD-L1 axis in human hepatocellular carcinomaDong-Ping Chen, Wan-Ru Ning, Ze-Zhou Jiang, et al.Radiology|August 28, 2009
Ethanol ablation of hepatocellular carcinoma Up to 5.0 cm by using a multipronged injection needle with high-dose strategyMing Kuang, Ming-De Lu, Xiao-Yan Xie, et al.Radiology|February 2, 2018
Advanced Recurrent Hepatocellular Carcinoma: Treatment with Sorafenib Alone or in Combination with Transarterial Chemoembolization and Radiofrequency AblationZhenwei Peng, Shuling Chen, Mengchao Wei, et al.Radiology|January 19, 2007
Liver cancer: increased microwave delivery to ablation zone with cooled-shaft antenna--experimental and clinical studiesMing Kuang, Ming D Lu, Xiao Y Xie, et al.BMC Medical Imaging|March 4, 2022
Differentiation between combined hepatocellular carcinoma and hepatocellular carcinoma: comparison of diagnostic performance between ultrasomics-based model and CEUS LI-RADS v2017Chao-Qun Li, Xin Zheng, Huan-Ling Guo, et al.Translational Oncology|October 19, 2020
Longitudinal radiomics algorithm of posttreatment computed tomography images for early detecting recurrence of hepatocellular carcinoma after resection or ablationJing-Xian Shen, Qian Zhou, Zhi-Hang Chen, et al.Journal of Hepatocellular Carcinoma|May 27, 2022
Application of the CT/MRI LI-RADS Treatment Response Algorithm to Contrast-Enhanced Ultrasound: A Feasibility StudySi-Min Ruan, Mei-Qing Cheng, Hui Huang, et al.Annals of Surgical Oncology|May 23, 2014
Preoperative aspartate aminotransferase to platelet ratio is an independent prognostic factor for hepatitis B-induced hepatocellular carcinoma after hepatic resectionShun-Li Shen, Shun-Jun Fu, Bin Chen, et al.Journal of Gastroenterology|December 3, 2005
Percutaneous microwave and radiofrequency ablation for hepatocellular carcinoma: a retrospective comparative studyMing-De Lu, Hui-Xiong Xu, Xiao-Yan Xie, et al.The Journal of Pathology|February 14, 2023
TUBB4B is a novel therapeutic target in non-alcoholic fatty liver disease-associated hepatocellular carcinomaZhenjie Yang, Shanshan Gao, Chi Chun Wong, et al.Pageof 48